Cargando…
Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders
Ca(v)1.3 belongs to the family of voltage‐gated L‐type Ca(2+) channels and is encoded by the CACNA1D gene. Ca(v)1.3 channels are not only essential for cardiac pacemaking, hearing and hormone secretion but are also expressed postsynaptically in neurons, where they shape neuronal firing and plasticit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823145/ https://www.ncbi.nlm.nih.gov/pubmed/26842699 http://dx.doi.org/10.1113/JP270672 |
_version_ | 1782425867150950400 |
---|---|
author | Pinggera, Alexandra Striessnig, Jörg |
author_facet | Pinggera, Alexandra Striessnig, Jörg |
author_sort | Pinggera, Alexandra |
collection | PubMed |
description | Ca(v)1.3 belongs to the family of voltage‐gated L‐type Ca(2+) channels and is encoded by the CACNA1D gene. Ca(v)1.3 channels are not only essential for cardiac pacemaking, hearing and hormone secretion but are also expressed postsynaptically in neurons, where they shape neuronal firing and plasticity. Recent findings provide evidence that human mutations in the CACNA1D gene can confer risk for the development of neuropsychiatric disease and perhaps also epilepsy. Loss of Ca(v)1.3 function, as shown in knock‐out mouse models and by human mutations, does not result in neuropsychiatric or neurological disease symptoms, whereas their acute selective pharmacological activation results in a depressive‐like behaviour in mice. Therefore it is likely that CACNA1D mutations enhancing activity may be disease relevant also in humans. Indeed, whole exome sequencing studies, originally prompted to identify mutations in primary aldosteronism, revealed de novo CACNA1D missense mutations permitting enhanced Ca(2+) signalling through Ca(v)1.3. Remarkably, apart from primary aldosteronism, heterozygous carriers of these mutations also showed seizures and neurological abnormalities. Different missense mutations with very similar gain‐of‐function properties were recently reported in patients with autism spectrum disorders (ASD). These data strongly suggest that CACNA1D mutations enhancing Ca(v)1.3 activity confer a strong risk for – or even cause – CNS disorders, such as ASD. [Image: see text] |
format | Online Article Text |
id | pubmed-4823145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-48231452016-04-18 Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders Pinggera, Alexandra Striessnig, Jörg J Physiol Symposium section reviews: Voltage‐gated calcium channels ‐ from basic mechanisms to disease Ca(v)1.3 belongs to the family of voltage‐gated L‐type Ca(2+) channels and is encoded by the CACNA1D gene. Ca(v)1.3 channels are not only essential for cardiac pacemaking, hearing and hormone secretion but are also expressed postsynaptically in neurons, where they shape neuronal firing and plasticity. Recent findings provide evidence that human mutations in the CACNA1D gene can confer risk for the development of neuropsychiatric disease and perhaps also epilepsy. Loss of Ca(v)1.3 function, as shown in knock‐out mouse models and by human mutations, does not result in neuropsychiatric or neurological disease symptoms, whereas their acute selective pharmacological activation results in a depressive‐like behaviour in mice. Therefore it is likely that CACNA1D mutations enhancing activity may be disease relevant also in humans. Indeed, whole exome sequencing studies, originally prompted to identify mutations in primary aldosteronism, revealed de novo CACNA1D missense mutations permitting enhanced Ca(2+) signalling through Ca(v)1.3. Remarkably, apart from primary aldosteronism, heterozygous carriers of these mutations also showed seizures and neurological abnormalities. Different missense mutations with very similar gain‐of‐function properties were recently reported in patients with autism spectrum disorders (ASD). These data strongly suggest that CACNA1D mutations enhancing Ca(v)1.3 activity confer a strong risk for – or even cause – CNS disorders, such as ASD. [Image: see text] John Wiley and Sons Inc. 2016-02-29 2016-10-15 /pmc/articles/PMC4823145/ /pubmed/26842699 http://dx.doi.org/10.1113/JP270672 Text en © 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Symposium section reviews: Voltage‐gated calcium channels ‐ from basic mechanisms to disease Pinggera, Alexandra Striessnig, Jörg Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders |
title | Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders |
title_full | Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders |
title_fullStr | Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders |
title_full_unstemmed | Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders |
title_short | Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders |
title_sort | ca(v)1.3 (cacna1d) l‐type ca(2+) channel dysfunction in cns disorders |
topic | Symposium section reviews: Voltage‐gated calcium channels ‐ from basic mechanisms to disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823145/ https://www.ncbi.nlm.nih.gov/pubmed/26842699 http://dx.doi.org/10.1113/JP270672 |
work_keys_str_mv | AT pinggeraalexandra cav13cacna1dltypeca2channeldysfunctionincnsdisorders AT striessnigjorg cav13cacna1dltypeca2channeldysfunctionincnsdisorders |